In addition, we identified recurrent CNVs in regions of well-recognized cancer-driving genes (EGFR, MTOR, CCND1, and MYC) or tumor suppressor gene (RB1), with a relatively higher variation in the DN and T stages (Supplementary Fig. S2b). This evidence concerns the gene CCND1 and cancer.